A detailed history of Fairvoy Private Wealth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fairvoy Private Wealth, LLC holds 5,289 shares of BMY stock, worth $247,578. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,289
Previous 7,199 26.53%
Holding current value
$247,578
Previous $325 Million 12.12%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 14, 2026

SELL
$42.6 - $49.08 $81,366 - $93,742
-1,910 Reduced 26.53%
5,289 $285 Million
Q3 2025

Oct 10, 2025

SELL
$43.31 - $48.98 $18,103 - $20,473
-418 Reduced 5.49%
7,199 $325 Million
Q2 2025

Jul 21, 2025

SELL
$44.12 - $59.6 $833,647 - $1.13 Million
-18,895 Reduced 71.27%
7,617 $353 Million
Q1 2025

Apr 17, 2025

BUY
$53.9 - $63.11 $247,239 - $289,485
4,587 Added 20.92%
26,512 $1.62 Billion
Q4 2024

Jan 28, 2025

BUY
$51.92 - $59.94 $1.14 Million - $1.31 Million
21,925 New
21,925 $1.24 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fairvoy Private Wealth, LLC Portfolio

Follow Fairvoy Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairvoy Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairvoy Private Wealth, LLC with notifications on news.